LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...
Giant cell arteritis (GCA), also known as temporal arteritis is a chronic inflammatory vasculitis that predominately affects large- and medium-sized arteries in individuals above the age of 50. More notably, GCA affects the cranial branches of the c...
The Sheer Scale of the Problem While dementia is usually regarded as a disorder of old age, it can invariably also affect younger individuals under the age of 65 1 . Early-onset dementia (EOD), also known as young-onset dementia (YOD), is defined as...
Migraine as the second most disabling disease contributes to significant prevalence at 18% in women and 9% in men. Despite maybe 4 out of 10 migraine patients could potentially benefit from migraine preventive medicines, but the utilization of and a...
Mediterranean diet (MD) has gained renowned reputation for its benefits to metabolic health, especially reducing the risk of cardiovascular events. The diet features an unambiguous combination of nutrients that encourages higher intake of dietary fi...
Insomnia disorder is a prevalent condition that affects millions globally (perhaps including you!) While often being overlooked, insomnia disorder is characterised by difficulty initiating or maintaining sleep over a sustained period. Apart from sle...
The Burden and Unmet Needs in Epileptic Sufferers EEpilepsy is one of the most common neurological conditions, with a prevalence of 0.5% to 1% 1 . It is considered a chronic brain disorder that affects people of all ages without geographical, social...
Migraine remains the second among the world's leading causes of disability and first among young females.1 Migraine attacks significantly impair a patient's quality of life and contribute to substantial economic burdens. In this regard, prev...
Vyepti ® ( Eptinezumab ) 6-7 Lundbeck Eptinezumab is a recombinant humanized monoclonal antibody that selectively inhibits calcitonin generelated peptide (CGRP) Compositio n : Available as a 100 mg/1mL concentrated solution for infusion Indica...
Shortage of healthcare manpower is a common issue faced by many societies, including mental health professionals. It affects the access to relevant services and taxes on the cost for utilization as a result. Digital mental health applications are th...
The health benefits of physical activity are undeniable, especially in reducing the risk of cardiovascular diseases and various cancers. More than the prevention of ill health, being physical active indeed promotes better functional capacity and rec...
Autoimmune disorders, such as rheumatoid arthritis, psoriasis, systemic sclerosis, lupus erythematosus, and type 1 diabetes, were found to be linked with increased CV risks, with risk dependent on the types of autoimmune disorders. In a population-b...
